Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Sees Large Decrease in Short Interest

Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Rating) was the recipient of a significant decline in short interest during the month of April. As of April 30th, there was short interest totalling 9,600 shares, a decline of 17.2% from the April 15th total of 11,600 shares. Based on an average daily volume of 7,600 shares, the days-to-cover ratio is presently 1.3 days.

Institutional Investors Weigh In On Alpha Tau Medical

Several large investors have recently made changes to their positions in the company. Goldman Sachs Group Inc. bought a new stake in Alpha Tau Medical during the first quarter worth approximately $42,000. Chicago Partners Investment Group LLC bought a new stake in Alpha Tau Medical during the first quarter worth approximately $55,000. Jane Street Group LLC bought a new stake in Alpha Tau Medical during the first quarter worth approximately $64,000. Whitebox Advisors LLC bought a new stake in Alpha Tau Medical during the third quarter worth approximately $65,000. Finally, Walleye Trading LLC purchased a new position in shares of Alpha Tau Medical during the first quarter valued at approximately $65,000.

Alpha Tau Medical Stock Up 23.0 %

Shares of DRTSW stock opened at $0.37 on Friday. Alpha Tau Medical has a 12-month low of $0.18 and a 12-month high of $1.00. The stock’s 50-day moving average price is $0.28 and its 200-day moving average price is $0.31.

About Alpha Tau Medical

(Get Rating)

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, lung, and prostate cancers.